Delivery Order SPE2DR25D2014-SPE2DR26FZ65K
- Not listed
- The Defense Logistics Agency awarded a $1,638.08 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous form. The contract employs firm fixed price terms with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with dextrose solution, a commonly used antibiotic pharmaceutical product. The contract was competitively awarded on June 5, 2025, with an ultimate completion date of June 6, 2025, and reflects a firm fixed-price arrangement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,630.47 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses, an antibiotic pharmaceutical product. The contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextrose, a pharmaceutical product used primarily as an antibiotic in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50mL with dextrose, an antibiotic pharmaceutical product. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,612.07 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextroses, an antibiotic pharmaceutical product. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and utilizes firm fixed pricing. The contract was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the vendor's...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solution, valued at $1,228.56, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,025.80 to AmerisourceBergen Drug Corp for the supply of Cefazolin 1 G/50 ML with dextroses. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ65KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,189.38 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML-Dextroses, an antibiotic medication used in clinical settings. This firm fixed price delivery order, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This contract falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement across the Defense Health Agency and other federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts focused on supplying medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's demonstrated capability to compete successfully in open procurement processes and deliver across a wide range of pharmaceutical products—from generic antibiotics to specialty medications—underscores its critical role in supporting the Defense Logistics Agency's medical supply chain requirements. This delivery order represents one of numerous transactions under AmerisourceBergen's prime vendor relationship with DLA, enabling flexible and responsive medical product support to federal healthcare customers globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/7/25 |